Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

The idea of using 212Pb for medical purposes germinated in the mind of Patrick Bourdet, Orano Med's founder. In the early 2000s, Areva (now Orano) looked at opportunities to use material derived from its core nuclear energy activities. Nuclear medicine and Targeted Alpha Therapy quickly appeared very promising: tangible scientific prospects but problematic supply of isotopes that could be overcome. With sufficient resources to...
The idea of using 212Pb for medical purposes germinated in the mind of Patrick Bourdet, Orano Med's founder. In the early 2000s, Areva (now Orano) looked at opportunities to use material derived from its core nuclear energy activities. Nuclear medicine and Targeted Alpha Therapy quickly appeared very promising: tangible scientific prospects but problematic supply of isotopes that could be overcome. With sufficient resources to produce 212Pb in larger quantities, the project soon emerged to demonstrate the feasibility of extracting and purifying this isotope. Successful results followed by conclusive preclinical studies

List your booth number for exhibitions, ask us

Contact Oranomed and get a quotation

Oranomed is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of Alphamedix bulk with DMF offered by Oranomed

Find a price of Lead bulk with DMF offered by Oranomed